ZINZINO AB (PUBL) Inactive Instrument
Zinzino AB (publ) Share Price Nasdaq Stockholm
Equities
SE0002480442
Other Specialty Retailers
| Sales 2023 | 1.77B 161M 12.86B | Sales 2024 * | 1.92B 174M 13.95B | Capitalization | 2.51B 228M 18.3B |
|---|---|---|---|---|---|
| Net income 2023 | 164M 14.91M 1.19B | Net income 2024 * | 179M 16.28M 1.3B | EV / Sales 2023 | 1.29 x |
| Net Debt 2023 | 257M 23.38M 1.87B | Net Debt 2024 * | 221M 20.09M 1.61B | EV / Sales 2024 * | 1.43 x |
| P/E ratio 2023 |
12.6
x | P/E ratio 2024 * |
14.6
x | Employees | - |
| Yield 2023 |
5.03% | Yield 2024 * |
2.71% | Free-Float | 53.08% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 31/12/11 | |
Fredrik Nielsen
DFI | Director of Finance/CFO | 47 | 31/12/08 |
| Chief Tech/Sci/R&D Officer | 48 | 31/12/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 31/12/06 | |
Anna Maria Frick
BRD | Director/Board Member | 56 | - |
| Director/Board Member | 52 | - |
Zinzino AB is a Sweden-based global Company engaged in selling dietary supplements, skin care and lifestyle products. The Company specializes in biomarker-based, personalized nutrition and health tech. The Companyâs test-based, scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino AB owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The Companyâs headquarter is in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia and India.
Sector
Other Specialty Retailers
Calendar
21/05/2024
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 843M | |
| -1.57% | 652M | |
| +2.69% | 372M | |
| -.--% | 143M | |
| +110.87% | 58.68M |
